期刊
BIOLOGICAL & PHARMACEUTICAL BULLETIN
卷 36, 期 12, 页码 1950-1958出版社
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.b13-00561
关键词
osthole; Alzheimer's disease; cyclic AMP response element-binding protein; beta-amyloid peptide(25-35)
资金
- National Nature Science Foundation of China [81173580]
- Liaoning Province Nature Science Foundation [201102144]
- Liaoning Province Excellent Talents Project
- Special Fund Project for Technology Innovation of Shenyang City [F11-264-1-42]
Accumulation of beta-amyloid peptide (A beta) in the brain plays an important role in the pathogenesis of Alzheimer's disease (AD). Previous studies have demonstrated the neuroprotective role of osthole against oxygen and glucose deprivation in cortical neurons. However, the effects of osthole on A beta-induced neurotoxicity in neural cells have rarely been reported. The current study was designed to investigate the protective effects of osthole on a cell model of AD insulted by exogenous A beta(25-35) and the potential mechanism(s). In this study, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, immunofluorescence analysis, apoptosis assay, reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) techniques were used in primary cortical neurons and SH-SY5Y cells. Our data showed that osthole reduced intracellular A beta levels in neural cells, which was associated with decreased BACE1 protein; osthole reversed exogenous A beta(25-35)-induced cell viability loss, apoptosis, and synapsin-1 reduction, which was related to the reestablishment of phosphorylation of cyclic AMP response element-binding protein (CREB). The collective evidence indicates that osthole possesses the ability to protect cortical neurons and SH-SY5Y cells against A beta injury, and the underlying mechanism may be attributed to the enhancement of CREB phosphorylation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据